By Matt Zollman, Director of Operations and Product Management
In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in mind that we announce an update to our 13710: Novel Emerging Compounds Panel. Beginning with orders placed on or after November 8th, 2021, the 13710: Novel Emerging Compounds Panel will include the following compounds, in addition to those already in the panel:
- AP-237
- Butonitazene
- Etonitazene
- Flunitazene
- Fluorofentanyl
Attached you will find our most recent publications for our 13710: Novel Emerging Compounds Panel (Panel Specifications). Additionally, you can always find the most recent publication for our panel offerings on our Test Catalog, found at www.axisfortox.com.
For specific questions regarding our tests or tests not found on our Test Catalog, please contact our Lab Client Support Team at labclientsupport@axisfortox.com.
We look forward to serving you.